Pfizer Inc - רווח למניה ב-12 החודשים האחרונים PFE

Following the decline in vaccine demand, Pfizer Inc. (PFE) is focusing on oncology and new assets. A powerful team of scientists with premium funding serves as the pillar of growth. The year-over-year change in EPS (TTM) visualizes this trend, where the value -59.10 acts as the target level. However, international profits remain vulnerable due to geopolitical risks and logistical disruptions in raw material supplies.

Investors are assessing the fundamental resilience of Pfizer Inc. (PFE) through the stability of its earnings per share. Geopolitical instability and vaccine logistics disruptions could significantly constrain these growth rates. By analyzing the historical EPS YoY TTM delta, the user observes smoothed revenue dynamics that neutralize the difference between GAAP and Non-GAAP standards. This asset requires a balance between current yield and volatility risk.